Arkolith/Insider Trading/FWBI/Form 4

Khosla Chaitan PHD

DirectorFirst Wave BioPharma, Inc. (FWBI) · full profile →Form 4 · filed Mar 15, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
1 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 13, 2024Grant(A)440——440

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 13, 2024Grant(A)53K——53K
Mar 13, 2024Grant(A)141——141

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-24-010162) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML